New nanovesicle therapy shows promise for treating alcohol-related liver disease
Alcohol-related liver disease (ALD) is characterized by hepatocellular injury, oxidative stress, inflammation, and extracellular matrix remodeling, yet effective therapies remain limited.
Read original article on The Medical News →Related news
-
Generative AI fills gaps in brain wiring maps where MRI scans lose signal
United Kingdom
-
WHO hails progress against neglected tropical diseases
United Kingdom
-
Exposure to petroleum-based lubricants at work associated with multiple sclerosis risk
United Kingdom
-
WHO approves clinical trials on two new Ebola vaccines
United Kingdom
-
Longer estrogen exposure linked to better brain vessel health in older women
United Kingdom
-
Some 1,800 dead from cholera in Ebola-hit DR Congo: WHO
United Kingdom
-
Blood pressure medication and vibration may boost brain waste clearance
United Kingdom
-
Frankfurt says airport malaria cases likely from West Africa
United Kingdom